Search

everythinglearnresearchcommunity

for

Search:↓

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

Kerion cases had longer disease duration but responded well to antifungal treatments.

Early symptoms of SLE include fatigue, joint pain, and sensitivity to sunlight.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Pregnancy can cause various skin changes and diseases, with PUPPP being the most common skin condition specific to pregnancy.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Lupus hepatitis can affect male SLE patients and is treatable with specific medications.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

More skin lesions in lupus patients may indicate higher disease activity.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Vitamin D is important for skin health and can affect various skin diseases.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Alopecia areata patients have a higher risk of other immune-related diseases.